PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CPRX vs. XPEL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CPRXXPEL
YTD Return-7.26%-32.70%
1Y Return18.74%-55.73%
3Y Return (Ann)39.40%-25.24%
5Y Return (Ann)34.28%48.81%
10Y Return (Ann)20.42%40.25%
Sharpe Ratio0.41-0.95
Daily Std Dev43.58%59.09%
Max Drawdown-94.25%-99.79%
Current Drawdown-25.94%-64.26%

Fundamentals


CPRXXPEL
Market Cap$1.81B$1.07B
EPS$0.56$1.74
PE Ratio27.3822.33
Total Revenue (TTM)$411.35M$400.56M
Gross Profit (TTM)$347.75M$164.33M
EBITDA (TTM)$114.04M$66.50M

Correlation

-0.50.00.51.00.1

The correlation between CPRX and XPEL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CPRX vs. XPEL - Performance Comparison

In the year-to-date period, CPRX achieves a -7.26% return, which is significantly higher than XPEL's -32.70% return. Over the past 10 years, CPRX has underperformed XPEL with an annualized return of 20.42%, while XPEL has yielded a comparatively higher 40.25% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%3,500.00%2024FebruaryMarchAprilMayJune
155.57%
1,911.10%
CPRX
XPEL

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Catalyst Pharmaceuticals, Inc.

XPEL, Inc.

Risk-Adjusted Performance

CPRX vs. XPEL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and XPEL, Inc. (XPEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CPRX
Sharpe ratio
The chart of Sharpe ratio for CPRX, currently valued at 0.41, compared to the broader market-2.00-1.000.001.002.003.000.41
Sortino ratio
The chart of Sortino ratio for CPRX, currently valued at 0.85, compared to the broader market-4.00-2.000.002.004.006.000.85
Omega ratio
The chart of Omega ratio for CPRX, currently valued at 1.11, compared to the broader market0.501.001.502.001.11
Calmar ratio
The chart of Calmar ratio for CPRX, currently valued at 0.40, compared to the broader market0.002.004.006.000.40
Martin ratio
The chart of Martin ratio for CPRX, currently valued at 1.52, compared to the broader market0.0010.0020.001.52
XPEL
Sharpe ratio
The chart of Sharpe ratio for XPEL, currently valued at -0.95, compared to the broader market-2.00-1.000.001.002.003.00-0.95
Sortino ratio
The chart of Sortino ratio for XPEL, currently valued at -1.18, compared to the broader market-4.00-2.000.002.004.006.00-1.18
Omega ratio
The chart of Omega ratio for XPEL, currently valued at 0.79, compared to the broader market0.501.001.502.000.79
Calmar ratio
The chart of Calmar ratio for XPEL, currently valued at -0.82, compared to the broader market0.002.004.006.00-0.82
Martin ratio
The chart of Martin ratio for XPEL, currently valued at -1.51, compared to the broader market0.0010.0020.00-1.51

CPRX vs. XPEL - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.41, which is higher than the XPEL Sharpe Ratio of -0.95. The chart below compares the 12-month rolling Sharpe Ratio of CPRX and XPEL.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.002024FebruaryMarchAprilMayJune
0.41
-0.95
CPRX
XPEL

Dividends

CPRX vs. XPEL - Dividend Comparison

Neither CPRX nor XPEL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CPRX vs. XPEL - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, smaller than the maximum XPEL drawdown of -99.79%. Use the drawdown chart below to compare losses from any high point for CPRX and XPEL. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%2024FebruaryMarchAprilMayJune
-25.94%
-64.26%
CPRX
XPEL

Volatility

CPRX vs. XPEL - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 8.86%, while XPEL, Inc. (XPEL) has a volatility of 14.31%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than XPEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%2024FebruaryMarchAprilMayJune
8.86%
14.31%
CPRX
XPEL

Financials

CPRX vs. XPEL - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and XPEL, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items